summary
Introduced
01/05/2017
01/05/2017
In Committee
01/05/2017
01/05/2017
Crossed Over
Passed
Dead
12/31/2018
12/31/2018
Introduced Session
115th Congress
Bill Summary
Medicare Prescription Drug Price Negotiation Act of 2017 This bill amends title XVIII (Medicare) of the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. Current law prohibits CMS from doing so.
AI Summary
This bill, the Medicare Prescription Drug Price Negotiation Act of 2017, amends the Social Security Act to require the Centers for Medicare & Medicaid Services (CMS) to negotiate with pharmaceutical companies regarding prices for drugs covered under the Medicare prescription drug benefit. This is a change from current law, which prohibits CMS from negotiating drug prices. The bill requires the Secretary of Health and Human Services to negotiate lower drug prices on behalf of Medicare beneficiaries and mandates semi-annual reports to Congress on the negotiations and price discounts achieved.
Committee Categories
Budget and Finance
Sponsors (14)
Amy Klobuchar (D)*,
Tammy Baldwin (D),
Richard Blumenthal (D),
Cory Booker (D),
Sherrod Brown (D),
Maria Cantwell (D),
Al Franken (D),
Kamala Harris (D),
Maggie Hassan (D),
Tim Kaine (D),
Angus King (I),
Patrick Leahy (D),
Chris Murphy (D),
Jeanne Shaheen (D),
Last Action
Read twice and referred to the Committee on Finance. (on 01/05/2017)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://www.congress.gov/bill/115th-congress/senate-bill/41/all-info |
| BillText | https://www.congress.gov/115/bills/s41/BILLS-115s41is.pdf |
| Bill | https://www.congress.gov/115/bills/s41/BILLS-115s41is.pdf.pdf |
Loading...